↓ Skip to main content

Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer

Overview of attention for article published in New England Journal of Medicine, September 2021
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

news
51 news outlets
blogs
2 blogs
policy
1 policy source
twitter
132 X users
patent
1 patent
facebook
2 Facebook pages
reddit
4 Redditors
guideline
8 clinical guideline sources
podcasts
2 podcasts

Readers on

mendeley
626 Mendeley